Concepedia

Annette Tognela

AT

Statistics

Publications

7

Citations

310

H-Index

7

Active since

2015

Affiliations

Camden and Campbelltown Hospitals(Current)

Chris O’Brien Lifehouse

The University of Sydney

National Health and Medical Research Council

Royal North Shore Hospital

Annette Tognela is an author at Camden and Campbelltown Hospitals specializing in medicine, chemotherapy, and oncology.

ORCID

Publications per year

2015–2024

7

Publications

7

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Peter Grimison, Antony Mersiades, Adrienne Kirby et al. · Annals of Oncology · 2020 · 153 citations · Full text

, , +14

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Andrew R. Davidson, A.-S. Veillard, Annette Tognela et al. · Annals of Oncology · 2015 · 33 citations

, , +13

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Daphne Day, Lisa Grech, Mike Nguyen et al. · Vaccines · 2022 · 30 citations · Full text

, , +17

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Antony Mersiades, Annette Tognela, Paul Haber et al. · BMJ Open · 2018 · 27 citations · Full text

, , +17

Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial

Peter Grimison, Antony Mersiades, Adrienne Kirby et al. · Journal of Clinical Oncology · 2024 · 26 citations · Full text

, , +17

1–5 of 7